AI, Big Data will be the most impactful emerging technologies for pharma in 2023: GlobalData Read more
Enzene Biosciences raises $50 million to boost manufacturing capabilities and grow in global markets Read more
Inflation, drug pricing and reimbursement constraints will have the biggest negative impact on biopharma industry in 2023: GlobalData Read more
Pricing pressures and regulatory overhang affect margins of Indian pharma companies in FY2023: ICRA Read more
We will maintain a growth rate in the high teens for both (CDMO and API business) in the next few years Read more